CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV NASH-NAFLD
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
UEGW 2015     Banner2   IC-Hep
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Gluten-free diet may not influence immune-mediated diseases in celiac disease
04-29-2016
Vitamin K dosing needs boost in deficient Dutch infants
04-28-2016
Express Scripts plans fiercer fight against sudden drug price hikes
04-28-2016
Treatment responses remain poor in IgM light-chain amyloidosis
04-27-2016
View Complete News Library
 
 
May 25-28
49th ANNUAL MEETING- THE EUROPEAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION (ESPGHAN)
Athens, Greece
May 21-24
DDW 2016
San Diego, CA
June 11-15
AMERICAN TRANSPLANT CONGRESS
Boston, Massachusetts
September 9-11
10th Annual ILCA (INTERNATIONAL LIVER CANCER ASSOCIATION) Conference
Vancouver, Canada
View all Congresses
 
 
 
  Line  
  Featured Abstracts          
 
Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort
 
Sofosbuvir and Simeprevir without Ribavirin Effectively Treat Hepatitis C Virus Genotype 1 Infection after Liver Transplantation in a Two-Center Experience
 
GS-9857 in patients with chronic hepatitis C virus genotype 1-4 infection: a randomized, double-blind, dose-ranging phase 1 study
 
Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir
 
Hepatitis C Disease Burden in the United States in the Era of Oral Direct-Acting Antivirals
 
Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir
 
 
Overview of hepatitis B viral replication and genetic variability
 
Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy
 
Are current screening protocols for chronic hepatitis B virus infection adequate?
 
Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus
 
Valproic acid-induced hyperammonemia and minimal hepatic encephalopathy prevalence among psychiatric inpatients
 
Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia
 
 
A low-cost, user-friendly electroencephalographic recording system for the assessment of hepatic encephalopathy
 
Techniques for Transjugular Intrahepatic Portosystemic Shunt Reduction and Occlusion
 
Randomized, Open-Label Phase 2 Study Comparing Frontline Dovitinib vs Sorafenib in Patients With Advanced Hepatocellular Carcinoma
 
Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis
 
Disentangling the effects of race and socioeconomic factors on liver transplantation rates for hepatocellular carcinoma
 
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer
 
 
          View All Abstracts  
  Line  
                     
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Telewebs
Webcasts
Slide Library
Abstract Library
 
 
NASH/NAFLD
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
         
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2016 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.